Anya Biopharm Inc. (TPEX:7776)

Taiwan · Delayed Price · Currency is TWD

30.85

-3.20 (-9.40%)

At close: Jul 9, 2026

-9.13% (1Y)

Market Cap	1.51B -10.3%
Revenue (ttm)	16.27M -24.7%
Net Income	-64.02M
EPS	-1.30
Shares Out	49.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131,128
Open	32.50
Previous Close	34.05
Day's Range	29.40 - 34.00
52-Week Range	21.50 - 70.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Anya Biopharm

Anya Biopharm Inc., a pharmaceutical company, research and development of new biotech drugs, focusing on oral peptides and converting injectable drugs into oral formulations in Taiwan, the rest of Asia, and Europe. The company is also developing ANY002 and ANY004, oral GLP1 products; ANY003, a tnfα inhibitor; and ANY005. In addition, it engages in the research, development, and testing business. Anya Biopharm Inc. was founded in 2016 and is based in Taipei, Taiwan. [Read more]

Industry Pharmaceutical Preparations

Founded 2016

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7776

Full Company Profile

Financial Performance

In 2025, Anya Biopharm's revenue was 16.27 million, a decrease of -24.66% compared to the previous year's 21.60 million. Losses were -64.02 million, 73.2% more than in 2024.

Financial Statements